Life Spine Files Lawsuit Against Former CEO Michael Butler for Breaches of Fiduciary Duties and Contracts, Trade Secret Misappropriation, and Tortious Interference
In the lawsuit, Life Spine alleges that Mr. Butler wrongfully diverted hundreds of thousands of dollars from the company through a sham importer entity he controlled and funded with Life Spine resources, directed the company to pay his personal expenses in amounts very likely exceeding $1 million—including vacations, jewelry, custom golf clubs and a Porsche for his spouse—and retained possession of highly sensitive intellectual property after his termination. The complaint further alleges that Butler has interfered with Life Spine's critical overseas manufacturing relationships and attempted to sabotage strategic business transactions by sharing non-public information.
'Life Spine takes seriously its duty to protect its employees, partners, and customers from any misconduct that threatens our operations,' said a company spokesperson.
The lawsuit is pending in the Chancery Division of the Cook County Circuit Court in Case No. 2025 CH 06287. Life Spine is represented by Michael T. Layden, David Jorgensen, and Jon Spanbauer of Croke Fairchild Duarte & Beres LLC.
About Life Spine
Founded in 2004 and headquartered in Huntley, Illinois, Life Spine is dedicated to developing innovative, high-quality medical devices that improve the lives of patients suffering from spinal disorders. The company's comprehensive portfolio includes advanced spinal implants, instruments, and procedural solutions for minimally invasive surgery.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
3 minutes ago
- Business Wire
Shareholder Alert: The Ademi Firm investigates whether Guess Inc. is obtaining a Fair Price for its Public Shareholders
MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Guess (NYSE: GES) for possible breaches of fiduciary duty and other violations of law in its transaction with Authentic Brands and the co-founders. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ or toll-free: 866-264-3995. There is no cost or obligation to you. Shareholders of Guess will receive $16.75 per share in cash or approximately $1.4 billion, including debt. Guess insiders will receive substantial benefits as part of change of control arrangements. The transaction agreement unreasonably limits competing transactions for Guess by imposing a significant penalty if Guess accepts a competing bid. We are investigating the conduct of the Guess board of directors, and whether they are fulfilling their fiduciary duties to all shareholders. We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
Business Wire
3 minutes ago
- Business Wire
Securities Fraud Investigation Into AVITA Medical, Inc. (RCEL) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
LOS ANGELES--(BUSINESS WIRE)-- The Law Offices of Frank R. Cruz announces an investigation of AVITA Medical, Inc. ('Avita' or the 'Company') (NASDAQ: RCEL) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON AVITA MEDICAL, INC. (RCEL), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On August 7, 2025, Avita released its second quarter 2025 financial results, revealing 'a six-month backlog in unpaid provider claims for Recell procedures impacted first-half demand.' The Company explained that contractors assigned by the Centers for Medicare & Medicaid Services to determine pricing of the Company's wound care product, Recell, 'neither assigned a price or assigned an inadequate price and failed to adjudicate claims in a timely manner.' As a result, 'claims accumulated from January through June, creating a significant backlog of unpaid claims and inadequately paid claims to providers for RECELL procedures. This lack of resolution created uncertainty among providers regarding payment expectations and timelines, which led to a reduction in RECELL utilization during the first half of the year.' On this news, Avita's stock price fell $1.13, or 21%, to close at $4.25 per share on August 8, 2025, thereby injuring investors. Contact Us To Participate or Learn More: If you purchased Avita securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us: The Law Offices of Frank R. Cruz 2121 Avenue of the Stars, Suite 800 Century City, California 90067 Call us at: 310-914-5007 Email us at: info@ Visit our website at: Follow us for updates on Twitter at If you inquire by email, please include your mailing address, telephone number, and number of shares purchased. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Business Wire
32 minutes ago
- Business Wire
Cantor Equity Partners IV, Inc. Announces Pricing of $400 Million Initial Public Offering
NEW YORK--(BUSINESS WIRE)--Cantor Equity Partners IV, Inc. (Nasdaq: CEPF) (the 'Company') announced today the pricing of its initial public offering of 40,000,000 Class A ordinary shares at $10.00 per share. The shares are expected to be listed on the Nasdaq Global Market under the symbol 'CEPF' and begin trading on August 21, 2025. The underwriters have been granted a 45-day option to purchase up to an additional 6,000,000 shares offered by the Company to cover over-allotments, if any. The offering is expected to close on August 22, 2025, subject to customary closing conditions. Cantor Fitzgerald & Co. is acting as the sole book-running manager for the offering. About Cantor Equity Partners IV, Inc. Cantor Equity Partners IV, Inc. is a blank check company sponsored by Cantor Fitzgerald and led by Chairman and Chief Executive Officer Brandon Lutnick. Cantor Equity Partners IV, Inc. was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company's efforts to identify a prospective target business will not be limited to a particular industry or geographic region, but the Company intends to focus on a target in an industry where it believes the Company's management teams' and affiliates' expertise will provide the Company with a competitive advantage, including the financial services, digital assets, healthcare, real estate services, technology and software industries. A registration statement relating to these securities was declared effective by the Securities and Exchange Commission (the 'SEC') on August 20, 2025. The offering is being made only by means of a prospectus, copies of which may be obtained by contacting Cantor Fitzgerald & Co., Attention: Capital Markets, 110 East 59th Street, 6th Floor New York, New York 10022; Email: prospectus@ Copies of the registration statement can be accessed through the SEC's website at This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Forward-Looking Statements This press release includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts. Such forward-looking statements, including with respect to the successful consummation of the Company's initial public offering and use of the net proceeds of the offering as described in the offering prospectus, are subject to risks and uncertainties including those set forth in the Risk Factors section of the Company's registration statement for the offering filed with the SEC, which could cause actual results to differ from the forward-looking statements. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.
